These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 452073)

  • 21. Plateletpheresis for postsplenectomy rebound thrombocytosis in a patient with chronic immune thrombocytopenic purpura on romiplostim.
    Raval JS; Redner RL; Kiss JE
    J Clin Apher; 2013 Aug; 28(4):321-4. PubMed ID: 23450778
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Donor platelet response and product quality assurance in plateletpheresis.
    Lasky LC; Lin A; Kahn RA; McCullough J
    Transfusion; 1981; 21(3):247-60. PubMed ID: 7233509
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Primary thrombocytosis and plateletpheresis--2 cases].
    Maeda H; Sueyoshi A; Iwanaga T; Horiuchi A
    Rinsho Ketsueki; 1982 Oct; 23(10):1651-5. PubMed ID: 7154264
    [No Abstract]   [Full Text] [Related]  

  • 24. Primary thrombocythemia: a current perspective.
    Mughal TI
    Stem Cells; 1995 Jul; 13(4):355-9. PubMed ID: 7549894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improvement of platelet aggregation abnormalities in thrombocytosis after thrombocytopheresis.
    Fabris F; Belloni M; Casonato A; Randi M; Ongaro G; Girolami A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(6):853-62. PubMed ID: 6176511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Function and morphology of platelets produced for transfusion by intermittent-flow centrifugation plateletpheresis or combined platelet-leukapheresis.
    Maguire LC; Henriksen RA; Strauss RG; Stein MN; Goedken MM; Echternacht B; Koepke JA; Thompson JS
    Transfusion; 1981; 21(1):118-23. PubMed ID: 6162254
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Plateletpheresis in primary thrombocythemia].
    Suzuki K; Asano Y; Yokoyama S; Tomoyasu S; Nunogami N
    Rinsho Ketsueki; 1982 Oct; 23(10):1661-7. PubMed ID: 7154265
    [No Abstract]   [Full Text] [Related]  

  • 28. Long-term plateletpheresis of a donor.
    Bongiovanni MB; Katz RS; Wurzel HA
    Transfusion; 1980; 20(4):465-6. PubMed ID: 6773193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Redistribution of platelets during discontinous flow platelet pheresis.
    Katz AJ; Reiss RF; Houx JA
    Vox Sang; 1978; 35(5):345-9. PubMed ID: 695447
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coagulation tests, blood loss, and transfusion requirements in platelet-rich plasmapheresed versus nonpheresed cardiac surgery patients.
    Wong CA; Franklin ML; Wade LD
    Anesth Analg; 1994 Jan; 78(1):29-36. PubMed ID: 8267176
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of excessive thrombocythemia in chronic myeloid leukemia by thrombocytopheresis and intravenous Thio-TEPA.
    Renner D; Queisser U; Martinez C; Queisser W
    Onkologie; 1987 Oct; 10(5):324-6. PubMed ID: 3120070
    [No Abstract]   [Full Text] [Related]  

  • 32. Therapeutic cytapheresis: too many platelets, too many white blood cells.
    Duvall D
    J Clin Apher; 2011; 26(1):47-52. PubMed ID: 21312258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reversible acute sensorineural hearing loss associated with essential thrombocytosis.
    Grisell DL; Mills GM
    Arch Intern Med; 1986 Sep; 146(9):1813. PubMed ID: 3753122
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 5-year incidence of thrombocytosis and the effect on heparin dose response and heparin requirements.
    Gayoso JM
    J Extra Corpor Technol; 1999 Dec; 31(4):184-90. PubMed ID: 10915475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The safety and performance of the Spectra Optia apheresis system platelet depletion protocol in patients with elevated platelet counts.
    Lopert P; Abdelrahman S; Graybill CA; Rhodes J; Sørensen B; Li M; Hu Y; Wu D; Liu L; He P; Zhang X; Huang F; Hu J; Bill J
    J Clin Apher; 2022 Dec; 37(6):544-552. PubMed ID: 36102144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful control of life-threatening thrombocytosis with a blood processor.
    Greenberg BR; Watson-Williams EJ
    Transfusion; 1975; 15(6):620-2. PubMed ID: 1198693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic thrombocytapheresis: a review of 132 patients.
    Adami R
    Int J Artif Organs; 1993 Dec; 16 Suppl 5():183-4. PubMed ID: 8013984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measurement of the levels of reticulated platelets after plateletpheresis to monitor activity of thrombopoiesis.
    Stohlawetz P; Stiegler G; Jilma B; Dettke M; Höcker P; Panzer S
    Transfusion; 1998 May; 38(5):454-8. PubMed ID: 9633558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thrombocytapheresis and sequential chemotherapy for extreme symptomatic thrombocytosis secondary to myelofibrosis: a case report.
    Debureaux PE; Brignier A; Soret-Dulphy J; Réa D; Michonneau D; Peffault de Latour R; Sicre de Fontbrune F; Pagliuca S; Parquet N; Prata HP; Marouf A; Xhaard A; Kiladjian JJ; Socié G; Robin M
    Ann Hematol; 2020 Apr; 99(4):897-898. PubMed ID: 32030449
    [No Abstract]   [Full Text] [Related]  

  • 40. Therapeutic thrombocytapheresis in a case of thrombocytosis.
    Belloni M; Fabris F; Ongaro G; Girolami A
    Transfusion; 1981; 21(2):229-30. PubMed ID: 7222208
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.